Article Text

Download PDFPDF
Gene therapy for beta-thalassaemia

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The list of life-limiting inherited conditions for which radically new gene-based treatments are appearing continues to grow. The latest is β-thalassaemia, which affects over ¼ million people worldwide. The majority of sufferers have a lifelong continuing blood transfusion requirement, with all the complications that come with it, such as iron overload. Those fortunate enough to have a compatible relative can sometimes be ‘cured’ by a bone marrow transplant, but that won’t work for many.

Virus vectors …

View Full Text


  • Provenance and peer review Commissioned; internally peer reviewed.